Barrington raised the firm’s price target on Adtalem Global Education to $65 from $55 and keeps an Outperform rating on the shares ahead of the fiscal Q2 report. The analyst cites expectations of an improving demand environment for Adtalem’s healthcare-focused programs and stronger year-over-year comps in the second half of the year for the target increase.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>